The impact of GST genetic polymorphisms on the response to oxaliplatin-based chemotherapy and survival prognosis in gastric cancer patients
The GSTP1 genotype status could be a valuable predictive biomarker for treatment response and survival, potentially facilitating more personalized therapeutic approaches for gastric cancer.
Authors
- Ji Zhang (ORCID: https://orcid.org/0000-0002-1832-4439)
- Tao Chen (ORCID: https://orcid.org/0000-0002-6552-3457)
- Qi Jin (ORCID: https://orcid.org/0000-0003-1681-9179)
- Xinyue Liu (ORCID: https://orcid.org/0000-0002-4094-3033)
Institutions
- Gansu Provincial Hospital (CN)
- Lanzhou University Second Hospital (CN)
- Gansu Provincial Center for Disease Control and Prevention (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Pharmacogenomics
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1080/14622416.2025.2583728
- Primary Topic
- Glutathione Transferases and Polymorphisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00